<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast CancerHermela Shimelis, Pascal Guénel, Romy L.S. Mesman et al.|Cancer Research|2017Cited by 93
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong Meeks, Pascal Guénel, Melissa C. Southey et al.|JNCI Journal of the National Cancer Institute|2015Cited by 92
The <i>BRCA2</i> c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Henrik Flyger, Irene López‐Perolio et al.|Human Mutation|2018Cited by 20
Human Evolutionary DemographyLisa Dillon, Hélène Vézina, Martin Dribe et al.|Open Book Publishers|2024Cited by 16
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.Hermela Shimelis, Pascal Guénel, Romy L.S. Mesman et al.|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2017Cited by 15